Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS

Clinical trial NCT07261072 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07261072
Sponsor: Peking Union Medical College
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Hidradenitis Suppurativa (HS)Hidradenitis Suppurativa (Acne Inversa)Secukinumab

Start date: 2025-12-01
Primary completion: 2026-11-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.